
    
      In this study, patients with oligo-metastatic prostate cancer will be randomized to radical
      prostatectomy plus standard care and standard care only. Standard care refers to androgen
      deprivation therapy (ADT) +/- other systemic therapies. Time to disease progression and
      post-treatment quality of life will be assessed and compared.
    
  